基因免疫中VP2增强VP6对轮状病毒的免疫原性和保护效力
研究将编码鼠轮状病毒VP2或VP6的DNA疫苗单独或联合肌内注射BALB/c小鼠三次,末次接种两周后用EDIMwt株攻击;pcDNA3-VP2与pcDNA3-VP6均能诱导轮状病毒特异性血清抗体但不诱导肠道特异性IgA,仅200µg pcDNA3-VP6诱导35%保护,100µg VP2/100µg VP6联合保护水平相似,10µg VP2/100µg VP6联合保护最高达58%。
要点
- pcDNA3-VP2和pcDNA3-VP6均诱导轮状病毒特异性血清抗体,但不诱导肠道轮状病毒特异性IgA。
- 仅200µg pcDNA3-VP6诱导35%保护;100µg VP2/100µg VP6联合保护水平相似。
- 10µg VP2/100µg VP6联合保护最高达58%,VP2共表达增强VP6免疫原性和保护效力。
核心结论
- 表达VP6的DNA质粒是比表达VP2更好的疫苗候选,但共表达时VP2增强VP6的免疫原性和保护效力。
研究设计与样本
- 将鼠轮状病毒VP2和VP6基因克隆入pcDNA3载体,成年BALB/c小鼠经肌内注射接种三次,分别给予100或200µg pcDNA3-VP2或pcDNA3-VP6单独或100µg pcDNA3-VP2/100µg pcDNA3-VP6联合,末次接种两周后用EDIMwt株攻击。
主要发现
- pcDNA3-VP2和pcDNA3-VP6均能诱导轮状病毒特异性血清抗体,但不诱导肠道轮状病毒特异性IgA。
- 仅200µg pcDNA3-VP6诱导35%保护。
- 100µg pcDNA3-VP2/100µg pcDNA3-VP6(1:1比例)联合时保护水平与200µg pcDNA3-VP6相似。
- 10µg pcDNA3-VP2/100µg pcDNA3-VP6(1:10比例)联合时保护最高达58%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
VP2/VP6 virus like particles (VLPs) are very effective in inducing protection against the rotavirus infection in animal models. Individually, VP6 can also induce protection. However, there is no information about the immunogenicity of VP2. The aim of this work was to evaluate the efficacy of DNA vaccines codifying for VP2 or VP6, alone or combined, to induce protection against the rotavirus infection. Murine rotavirus VP2 and VP6 genes were cloned into the pcDNA3 vector. Adult BALB/c mice were inoculated three times by intramuscular (i.m.) injections with 100 or 200µg of pcDNA3-VP2 or pcDNA3-VP6 alone or co-administered with 100µg of pcDNA3-VP2/100µg of pcDNA3-VP6. Two weeks after the last inoculation, mice were challenged with the wild type murine rotavirus strain epizootic diarrhea of infant mice (EDIMwt). We found that both plasmids, pcDNA3-VP2 and pcDNA3-VP6, were able to induce rotavirus-specific serum antibodies, but not intestinal rotavirus-specific IgA; only 200µg of pcDNA3-VP6 induced 35% protection against the infection. A similar level of protection was found when mice were co-administered with 100µg of pcDNA3-VP2/100µg of pcDNA3-VP6 (1:1 ratio). However, the best protection (up to 58%) occurred when mice were inoculated with 10µg of pcDNA3-VP2/100µg of pcDNA3-VP6 (1:10 ratio). These results indicate that the DNA plasmid expressing VP6 is a better vaccine candidate that the one expressing VP2. However, when co-expressed, VP2 potentiates the immunogenicity and protective efficacy of VP6.
引用
- Lopez-Guerrero DV, Arias N, Gutierrez-Xicotencatl L, et al. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization. Vaccine. 2017. PMID: 28465094. doi:10.1016/j.vaccine.2017.03.104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。